These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12968538)

  • 1. Adeno-associated viral vectors for Parkinson's disease.
    Muramatsu S; Wang L; Ikeguchi K; Fujimoto K; Nakano I; Okada T; Mizukami H; Hanazono Y; Kume A; Nakano I; Ozawa K
    Int Rev Neurobiol; 2003; 55():205-22. PubMed ID: 12968538
    [No Abstract]   [Full Text] [Related]  

  • 2. Gene therapy for Parkinson's disease using recombinant adeno-associated viral vectors.
    Muramatsu S; Tsukada H; Nakano I; Ozawa K
    Expert Opin Biol Ther; 2005 May; 5(5):663-71. PubMed ID: 15934841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The first steps towards gene therapy for Parkinson's disease.
    Svendsen C
    Lancet Neurol; 2007 Sep; 6(9):754-6. PubMed ID: 17706556
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapeutic Value of Adeno Associated Virus as a Gene Therapy Vector for Parkinson's Disease - A Focused Review.
    Singh A; Sen D
    Curr Gene Ther; 2016; 16(4):278-286. PubMed ID: 27487991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herpes simplex virus vectors for Parkinson's disease.
    Latchman DS
    Int Rev Neurobiol; 2003; 55():223-41. PubMed ID: 12968539
    [No Abstract]   [Full Text] [Related]  

  • 6. Viral vectors as a tool to model and treat Parkinson's disease.
    Bensadoun JC; Aebischer P
    Wien Klin Wochenschr; 2006 Oct; 118(19-20):568-70. PubMed ID: 17136329
    [No Abstract]   [Full Text] [Related]  

  • 7. CNS diseases amenable to gene therapy.
    Federoff HJ
    Ernst Schering Res Found Workshop; 2003; (43):117-58. PubMed ID: 12894455
    [No Abstract]   [Full Text] [Related]  

  • 8. Adeno-associated viral vectors.
    Lehtonen E; Tenenbaum L
    Int Rev Neurobiol; 2003; 55():65-98. PubMed ID: 12968531
    [No Abstract]   [Full Text] [Related]  

  • 9. Gene therapy of Parkinson's disease using adeno-associated virus (AAV) vectors.
    Ozawa K; Fan DS; Shen Y; Muramatsu S; Fujimoto K; Ikeguchi K; Ogawa M; Urabe M; Kume A; Nakano I
    J Neural Transm Suppl; 2000; (58):181-91. PubMed ID: 11128607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral vector delivery of neurotrophic factors for Parkinson's disease therapy.
    Kelly MJ; O'Keeffe GW; Sullivan AM
    Expert Rev Mol Med; 2015 May; 17():e8. PubMed ID: 25997719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current development of adeno-associated viral vectors.
    Romano G
    Drug News Perspect; 2005 Jun; 18(5):311-6. PubMed ID: 16193103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral vectors in the treatment of Parkinson's disease.
    Latchman DS; Coffin RS
    Mov Disord; 2000 Jan; 15(1):9-17. PubMed ID: 10634236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adeno-associated virus vectors for gene transfer to the brain.
    Okada T; Nomoto T; Shimazaki K; Lijun W; Lu Y; Matsushita T; Mizukami H; Urabe M; Hanazono Y; Kume A; Muramatsu S; Nakano I; Ozawa K
    Methods; 2002 Oct; 28(2):237-47. PubMed ID: 12413422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapeutic strategies for neuroprotection: implications for Parkinson's disease.
    Bowers WJ; Howard DF; Federoff HJ
    Exp Neurol; 1997 Mar; 144(1):58-68. PubMed ID: 9126153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy for Parkinson's disease: a step closer?
    Stoessl AJ
    Lancet; 2014 Mar; 383(9923):1107-9. PubMed ID: 24412047
    [No Abstract]   [Full Text] [Related]  

  • 16. Towards a neuroprotective gene therapy for Parkinson's disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model.
    Björklund A; Kirik D; Rosenblad C; Georgievska B; Lundberg C; Mandel RJ
    Brain Res; 2000 Dec; 886(1-2):82-98. PubMed ID: 11119690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scientific rationale for the development of gene therapy strategies for Parkinson's disease.
    Björklund T; Kirik D
    Biochim Biophys Acta; 2009 Jul; 1792(7):703-13. PubMed ID: 19254760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo adenovirus-mediated gene transfer for Parkinson's disease.
    Horellou P; Bilang-Bleuel A; Mallet J
    Neurobiol Dis; 1997; 4(3-4):280-7. PubMed ID: 9361305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herpes simplex virus vectors for gene therapy in Parkinson's disease and other diseases of the nervous system.
    Latchman DS
    J R Soc Med; 1999 Nov; 92(11):566-70. PubMed ID: 10703493
    [No Abstract]   [Full Text] [Related]  

  • 20. Parkinson's disease gene therapy: Will focused ultrasound and nanovectors be the next frontier?
    Price RJ; Fisher DG; Suk JS; Hanes J; Ko HS; Kordower JH
    Mov Disord; 2019 Sep; 34(9):1279-1282. PubMed ID: 30908781
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.